01—Abstract
Summary
Summary of the 10-Q filed August 3, 2023. Cited figures are marked; the original filing is the authoritative source.
Ecolab Inc. reported solid financial results for the second quarter and first six months of 2023, demonstrating revenue growth and improved profitability.
Net sales increased by 8%a year-over-year for both periods, driven by a combination of price increases and volume growth across most segments. The company saw particular strength in its Global Industrial and Global Institutional & Specialty segments, which experienced double-digit organic sales growth. Profitability also improved, with reported operating income up 14% and 23% for the respective periods.
The company is actively managing restructuring initiatives aimed at cost savings, with a significant portion of the anticipated charges expected to be completed by 2024. Despite ongoing inflationary pressures and global economic uncertainties, Ecolab maintained a strong financial position. The company's liquidity remains robust, supported by consistent cash flow from operations.
Management is focused on strategic growth initiatives, including targeted acquisitions, while also returning capital to shareholders through dividends and share repurchases. Ecolab's diversified business model and disciplined approach to cost management position it well to navigate the current economic landscape.
02—Key points
Key Highlights
- Net sales increased by 8% year-over-year for both the second quarter and the first six months of 2023, reaching $3.85 billion and $7.42 billion, respectively.
- Organic sales grew by 9% in the second quarter and 11% in the first six months, indicating strong underlying business performance driven by pricing and volume.
- Operating income saw significant increases, up 14% to $484.7 million in Q2 and 23% to $836.3 million in the first six months, reflecting effective cost management and pricing strategies.
- Restructuring initiatives, including the Combined Program, are underway with expected pre-tax charges of $195 million, aimed at achieving significant annualized cost savings.
- Acquisition of Chemlink Laboratories LLC in May 2023 strengthens the Global Institutional & Specialty segment.
- The company's financial position remains strong, with total assets of $21.5 billion and a net debt to EBITDA ratio of 3.0x as of June 30, 2023.
- Diluted EPS increased by 6% to $1.15 in Q2 and 18% to $1.97 in the first six months, demonstrating improved profitability on a per-share basis.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q2 FY2023, Ecolab Inc. kept $0.09.
- Revenue$3.85B100.0%
- Cost of revenue−$2.33B60.6%
- Gross profit$1.52B39.4%
- Operating costs−$1.03B26.8%
- Operating income$484.7M12.6%
- Interest, other & tax−$155.0M4.0%
- Net income$329.7M8.6%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2023filed August 3, 2023Financial Statements
Q2 FY2023 against Q2 FY2022
| Line item | Q2 FY2023Q2 FY2022 | Change |
|---|---|---|
| Revenue | $3.85B$3.58B | +7.6% |
| Cost of Revenue | $2.33B$2.21B | +5.6% |
| Gross Profit | $1.52B$1.37B | +10.8% |
| SG&A Expenses | $1.01B$940.10M | +7.6% |
| Operating Income | $484.70M$425.80M | +13.8% |
| Interest Expense | $82.70M$57.30M | +44.3% |
| Net Income | $329.70M$308.30M | +6.9% |
| EPS (Basic) | $1.16$1.08 | +7.4% |
| EPS (Diluted) | $1.15$1.08 | +6.5% |
| Shares Outstanding (Basic) | 284.90M285.10M | −0.1% |
| Shares Outstanding (Diluted) | 286.30M286.60M | −0.1% |
05—Questions
Frequently Asked Questions
What was the primary driver of Ecolab's sales growth in the second quarter and first six months of 2023?
Ecolab's sales growth was primarily driven by a combination of price changes and volume increases across its segments. Pricing actions were a significant contributor, helping to offset cost inflation, while positive volume trends were observed in key segments like Global Industrial and Global Institutional & Specialty.
How is Ecolab managing restructuring and cost-saving initiatives?
Ecolab is actively pursuing restructuring initiatives, notably the 'Combined Program,' which is expected to incur $195 million in pre-tax charges. These programs are designed to achieve significant cost savings, with an estimated $175 million in annualized savings expected from the Combined Program by 2024. The company is also progressing with other initiatives like the 'Institutional Advancement Program' and 'Accelerate 2020'.
What is the outlook for Ecolab's different business segments?
The Global Industrial and Global Institutional & Specialty segments showed robust performance with double-digit organic sales growth. The Global Healthcare & Life Sciences segment experienced modest growth, slightly offset by soft demand in the life sciences industry. The 'Other' segment, including Pest Elimination, also showed strong growth.
How is Ecolab's financial health and liquidity?
Ecolab maintains a strong financial position with total assets of $21.5 billion and a healthy net debt to EBITDA ratio of 3.0x. The company generated strong cash flow from operations ($771.6 million in the first six months of 2023), enabling it to fund operations, investments, and return capital to shareholders. Liquidity is further supported by a $2.0 billion revolving credit facility.
06—Continue